<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0DE6810-C22C-433E-9160-263AFCEF5D4D"><gtr:id>A0DE6810-C22C-433E-9160-263AFCEF5D4D</gtr:id><gtr:name>Ludger Ltd</gtr:name><gtr:address><gtr:line1>Culham Science Centre</gtr:line1><gtr:postCode>OX14 3EB</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/16513C09-7140-413B-AF1F-A7A878ADB3B9"><gtr:id>16513C09-7140-413B-AF1F-A7A878ADB3B9</gtr:id><gtr:name>CARLSBERG GROUP</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Pharmaceutical Sciences</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0DE6810-C22C-433E-9160-263AFCEF5D4D"><gtr:id>A0DE6810-C22C-433E-9160-263AFCEF5D4D</gtr:id><gtr:name>Ludger Ltd</gtr:name><gtr:address><gtr:line1>Culham Science Centre</gtr:line1><gtr:postCode>OX14 3EB</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/16513C09-7140-413B-AF1F-A7A878ADB3B9"><gtr:id>16513C09-7140-413B-AF1F-A7A878ADB3B9</gtr:id><gtr:name>CARLSBERG GROUP</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DB036394-9034-4494-9006-922B3027AFDA"><gtr:id>DB036394-9034-4494-9006-922B3027AFDA</gtr:id><gtr:firstName>Gerd</gtr:firstName><gtr:surname>Wagner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH024433%2F2"><gtr:id>BA6B01BF-F063-4B77-BCE3-1B86061CF99E</gtr:id><gtr:title>Screening Carbohydrate-Active Enzymes - a Fluorescent Solution</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H024433/2</gtr:grantReference><gtr:abstractText>In all domains of life, the formation of complex carbohydrates requires the concerted action of a multitude of glycosyltransferases (GTs), enzymes that catalyse the transfer of a sugar from a sugar-nucleotide donor onto an acceptor oligosaccharide chain. Such glycosylation reactions are central to many fundamental biological processes, such as cell signalling, cellular adhesion, carcinogenesis, the evasion of the immune system by human pathogens and, of particular interest in the context of this proposed study, the generation of the complex and dynamic 3D architecture that is the plant cell wall. In contrast to other protein families of comparable size and biological significance, our understanding of GT biology remains fragmented, due to a lack of molecular tools for the investigation of GT substrate specificity. Existing GT assays are generally labour- and/or cost-intensive and/or require specialist equipment. Our approach to this problem is through the design, synthesis and application of novel fluorescent sugar probes, which can be used to identify GTs and to determine their substrate specificity.</gtr:abstractText><gtr:technicalSummary>Novel fluorescent sugar nucleotide probes developed in the Wagner group possess several advantages over conventional fluorophores previously used in protein bioassays: (i) the structural difference to the natural donor substrate is minimal; (ii) the binding characteristics are very similar to those of the natural ligand; (iii) the chemical synthesis of the fluorescent sugar-nucleotides is straightforward; and (iv) the same synthetic strategy can be used for the development of different fluorescent UDP-sugars, both with regard to the identity of the sugar and the properties of the fluorophore. The novel fluorophores proposed herein are therefore ideally suited for the efficient development of fluorescent probes for the investigation of sugar-nucleotide- dependent enzymes.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>91849</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carlsberg Group</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Carlsberg Research Centre</gtr:department><gtr:description>Carlsberg Research Centre</gtr:description><gtr:id>DF49886B-F7D6-4572-8399-072B1AE7A975</gtr:id><gtr:outcomeId>b9c6b984b9c6b998-1</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludger Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Ludger Ltd</gtr:description><gtr:id>50117E4A-547E-4526-91AA-D6DB29DF267E</gtr:id><gtr:impact>no outputs yet</gtr:impact><gtr:outcomeId>56e009f880f3a8.05097363-1</gtr:outcomeId><gtr:partnerContribution>provision of unique glycoanalytics platform</gtr:partnerContribution><gtr:piContribution>provision of glycosyltransferase inhibitors for the development of optimised glycoprotein therapeutics</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>John Innes Centre</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>JIC</gtr:description><gtr:id>26E34051-2D68-424C-88A9-61556F705DA2</gtr:id><gtr:impact>Exploration of carbohydrate-active enzymes for the synthetic preparation of a novel class of non-natural sugar-nucleotides as fluorescent biological probes</gtr:impact><gtr:outcomeId>54647f4966c473.91393614-1</gtr:outcomeId><gtr:partnerContribution>enzymatic synthesis of novel fluorescent probes and structure-activity studies of carbohydrate-active enzymes</gtr:partnerContribution><gtr:piContribution>supply of synthetic reagents and intermediates for the enzymatic synthesis of novel fluorescent probes</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The findings have led to a new academic/industry collaboration with Ludger Ltd. The goal of this collaboration is the development and application of new biotechnological tools for affordable, high-performance anti-cancer immunotherapeutics</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>8D910AB2-1584-4275-B60B-D280A9BD8B35</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56e00e0012f3c1.34622117</gtr:outcomeId><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>development of fluorescent nucleotides and nucleotide-conjugates for applications in protein binding assays, e.g. for small molecular inhibitor screening</gtr:description><gtr:grantRef>BB/H024433/2</gtr:grantRef><gtr:id>FED769D2-7182-4E7F-9180-C0AFB9E11277</gtr:id><gtr:impact>this IP forms part of the ongoing collaboration with Ludger Ltd</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56e00b33e44d90.30878524</gtr:outcomeId><gtr:patentId>W02011/051733</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>DERIVATIVES OF URIDINE PHOSPHATE AND THEIR USES IN PROTEIN BINDING ASSAYS</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Small chemical probes can differentiate between different members of the same, large enzyme family, using a simple fluorescent read-out</gtr:description><gtr:exploitationPathways>These findings can be used for the development of new assays, inhibitors and biotechnological tools</gtr:exploitationPathways><gtr:id>4D3D33E9-E2DD-4880-9914-2749C81FA917</gtr:id><gtr:outcomeId>56e00d5bc37bb3.01164459</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A series of ca 10 new fluorescent probes for glycosyltransferases (GTs) has been prepared. The biological evaluation of the new materials as potential substrate analogues or inhibitors is ongoing.</gtr:description><gtr:id>EAA9912B-E357-4BD6-B724-51FC717C4AEB</gtr:id><gtr:impact>The new fluorescent probes are currently under investigation in recombinant and cellular assays, in collaboration with other research groups (Palcic/Copenhagen, Page/London)</gtr:impact><gtr:outcomeId>b7rLbA3xExU</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GT fluorescent probes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BB/H024433/2</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>